September 7, 2017
News
qPCR: The Weapon of Choice for Gene and Cell Therapy Biodistribution
To advance a gene or cell therapy product into clinical trials, drug developers must first gain a thorough...August 31, 2017
Lovelace Radiation Research in the Spotlight at National Convention
Lovelace Biomedical’s scientific team will share two recent examples of their advanced preclinical work in defining animal models...August 24, 2017
The Tools and Talent to Investigate the Flu: A Unique CRO Capability
It was nearly a century ago, in 1918, that an influenza pandemic swept the world, killing as many...August 17, 2017
FEATURED WEBINAR: Innovation in Aerosol Drug Formulations
Get an inside look into a 15-year collaboration between the scientists at Lovelace Biomedical and engineers at Capsugel,...August 10, 2017
Breathe Easy: Meeting the Preclinical Challenges of Pulmonary Fibrosis
The race is on for better therapies to treat pulmonary fibrosis, a chronic lung disease characterized by irreversible...August 3, 2017
Lovelace Biomedical Featured in The Scientist: Why Pharma Should Consider Canine Models for Alzheimer’s
The Scientist magazine recently featured an opinion article from Lovelace Biomedical Senior Scientist Edward Barrett, Ph.D., who shared his...March 8, 2017
Lovelace Biomedical’s Advances in Toxicological Research to be Featured at the 56th Annual Meeting of the Society of Toxicology
Albuquerque, N.M., March 8, 2017 – Lovelace Biomedical, a not-for-profit preclinical contract research organization, today announced its participation in...February 1, 2017
A Rich History, An Exciting Future
As you prepare to launch ambitious new projects in 2017, I’d like to personally encourage you to explore...January 25, 2017
Lovelace Biomedical to showcase expertise in inhalation drug delivery as hosts of the International Society of Aerosols in Medicine Congress
The Lovelace Respiratory Research Institute, including the commercially-focused CRO arm Lovelace Biomedical, has been a leader in inhalation...January 18, 2017
Lovelace Biomedical Welcomes Larry Mallis, Ph.D. as Director of Bioanalytical Operations and Further Expands Bioanalytical Chemistry Capabilities
Lovelace Biomedical welcomes Dr. Larry Mallis as Director of Bioanalytical Operations and a key member of the scientific...December 17, 2015
Addressing the Preclinical Development Challenges of Gene Therapy
While the concept of gene therapy has been around for decades, gene therapy companies are just beginning to...December 3, 2015
European Style Housing of Nonhuman Primates
In the United States, laboratory animal research requirements are defined by a combination of the Animal Welfare Act...October 13, 2015